Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT05121038
Title CEND-1 in Combination With Neoadjuvant FOLFIRINOX With or Without Panitumumab (CENDIFOX)
Acronym CENDIFOX
Recruitment Recruiting
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors Anup Kasi
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
The University of Kansas Cancer Center (KUCC) RECRUITING Fairway Kansas 66205 United States Details
The University of Kansas Cancer Center, Westwood Campus RECRUITING Kansas City Kansas 66205 United States Details
The University of Kansas Medical Center RECRUITING North Kansas City Missouri 64116 United States Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field